Latest Breaking News On - Avidity biosciences daily - Page 6 : comparemela.com

Avidity Biosciences (NASDAQ:RNA) Sees Unusually-High Trading Volume

Avidity Biosciences (NASDAQ:RNA) Sees Unusually-High Trading Volume
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sarah boyceW michael flanaganNisa investment advisorsSecurities exchange commissionChina universal asset management coAvidity biosciences incHsbc holdingsNeedham companyWells fargo companyAvidity biosciencesGet free reportExchange commissionInvestment advisorsInvestment managementUniversal asset managementAvidity biosciences daily

Avidity Biosciences, Inc (NASDAQ:RNA) CFO Michael F Maclean Sells 1,616 Shares

Avidity Biosciences, Inc (NASDAQ:RNA) CFO Michael F Maclean Sells 1,616 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelf macleanByrne asset managementRoyal bankNeedham companyAncora advisorsAvidity biosciences incWells fargo companyAvidity biosciencesGet free reportAvidity biosciences daily

Avidity Biosciences, Inc (NASDAQ:RNA) Director Arthur A Levin Sells 1,859 Shares

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the firm’s stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $10.13, for a total transaction of $18,831.67. Following the sale, the director now directly owns 17,471 shares in the company, […]

Arthura levinRoyal bankNeedham companyAvidity biosciences incAncora advisorsHsbc holdingsWells fargo companyAvidity biosciencesGet free reportDirector arthurBiosciences stock downInvestment managementAvidity biosciences dailyNasdaq rnaInsider tradingNsider trades

Insider Selling: Avidity Biosciences, Inc (NASDAQ:RNA) Insider Sells 4,129 Shares of Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) insider W. Michael Flanagan sold 4,129 shares of the company’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $41,826.77. Following the transaction, the insider now owns 35,871 shares in the company, valued […]

W michael flanaganPricet rowe associates incSecurities exchange commissionMillennium managementNeedham companyAvidity biosciences incMorgan stanleyWells fargo companyAvidity biosciences company profileAvidity biosciencesGet free reportExchange commissionBiosciences trading downStreet corpAvidity biosciences dailyNasdaq rna

Insider Selling: Avidity Biosciences, Inc (NASDAQ:RNA) Director Sells 1,859 Shares of Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $18,831.67. Following the transaction, the director now directly owns 17,471 shares of the […]

Arthura levinWells fargo companyAvidity biosciences incAncora advisorsNeedham companyRoyal bankByrne asset managementAvidity biosciencesGet free reportDirector arthurBiosciences stock downAvidity biosciences dailyNasdaq rnaInsider tradingNsider trades